ESWI activities

ESWI Respiratory Virus Summit 2024
5 March 2024
Brussels & online
ESWI Airborne: Burden of Disease
ESWI has launched a new podcast series addressing the burden of disease of acute respiratory virus infections.
9th Influenza Conference 2023
17 - 20 September 2023
Valencia
ESWI webinar series 2021
How can countries cope with more than one major respiratory virus spreading, while non- pharmaceutical interventions are being loosened week by week?

Agenda

2023
11
October
EU Flu Day 2023
European Parliament, Brussels & Online
The fourth edition of the EU Flu Day takes place on Wednesday 11 October at the European Parliament (Brussels) organised by the Steering Group on Influenza Vaccination
2023
12
October
MENA-ISN Influenza Day 2023: Unmet needs for influenza vaccination
Online
Unmet needs for influenza vaccination
2023
15-17
October
World Health Summit 2023
Berlin
The World Health Summit stands for a science-driven and broad approach to global health development
2023
16-19
October
World Vaccine Congress Europe 2023
Barcelona
The region's largest event dedicated to vaccine business, science and technology development
2023
2
November
APACI Respiratory Diseases Conference 2023
Singapore
Join APACI in exploring the latest advancements and challenges in respiratory health!
2023
8-10
November
Individual and population immunity to respiratory viruses
Hong Kong
Immunity to respiratory viruses can be conferred by infections or by vaccinations, and immunity plays a key role in infection dynamics

Education hub

News
|
The Ninth ESWI Influenza Conference: Highlights
ESWI 2023: 10 key take home messages
News
Australian discovery of change in ‘killer T cells’ could help fight against influenza
Research led by Dr Carolien van de Sandt, a senior research fellow at the Doherty Institute and 2023 Claude Hannoun Prize, and UNSW Sydney shows that cells are replaced as we get older by ones less able to read threat from infections
News
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
News
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

ESWI networks & communities

Influenza Diabetes Community

The Influenza Diabetes Community (IDC) unites scientists, healthcare professionals, patient -and other stakeholder organisations to discuss, share best practices and to network with the objective to raise awareness of the burden of influenza, Covid-19 and RSV in people living with diabetes.

Early Career Scientists Network

Some of the best and most innovative ideas come from early career scientists, they are the future of the influenza field. For this reason, ESWI has been actively encouraging the careers of early career scientists for many years.